Evaluating the Impact of MRP1 and MRP2 Polymorphisms on the Pharmacoresistance to Imatinib Treatment Among CML Patients

Evaluating the Impact of MRP1 and MRP2 Polymorphisms on the Pharmacoresistance to Imatinib Treatment Among CML Patients

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 24; p. ix76
Main Authors: Au, A., Baba, A.A., Goh, S.A., Wahid, F.S.A., Teh, A., Elias, M.H., Ankathil, R.
Format: Journal Article
Language:English
Published: 01-11-2013
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1093/annonc/mdt460.50